BackFidelity Advisor Biotechnology Fund Overview

Fidelity Advisor Biotechnology Fund Receivables

Latest receivables for FBTTX: $8.6M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$8.57M
↓ 44.26% YoYΔ $-6.80M vs prior year quarter

Peer trimmed avg / median

Loading

Fidelity Advisor Biotechnology Fund Receivables History

Loading

Fidelity Advisor Biotechnology Fund vs. peers: Receivables Comparison

Loading

Fidelity Advisor Biotechnology Fund Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Advisor Biotechnology Fund (FBTTX) FAQ

As of the most recent data (February 2024), FBTTX shows a receivables of $8.6M. That compares with $15M in the prior-year period — down 44.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBTTX's receivables is now $8.6M (was $15M) — a 44.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Fidelity Advisor Biotechnology Fund is outperforming or lagging.

Tracking FBTTX's receivables over time shows whether Fidelity Advisor Biotechnology Fund is scaling, shrinking, or reshaping that part of the business. The current reading is $8.6M That compares with $15M in the prior-year period — down 44.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Fidelity Advisor Biotechnology Fund's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $8.6M) with ownership activity and broader fundamentals.